NewGLAB Pharma CO.,LTD

A214870

KR7214870008

Phones & Handheld Devices

End-of-day quote Korea S.E. Other stock markets 04:30:00 09/03/2023 am IST			5-day change	1st Jan Change
1,383 ^KRW	-27.44%		-.--%	-.--%

04/03	NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI
22/02	NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	CI

Intelligent Digital Integrated Security Co., Ltd. acquired 49.55% stake in HD Pro Co.,Ltd. for KRW 8.2 billion.

October 31, 2012 at 09:30 am IST

Intelligent Digital Integrated Security Co., Ltd. (KOSE:A143160) acquired 49.55% stake in HD Pro Co.,Ltd. for KRW 8.2 billion on October 31, 2012. Intelligent Digital Integrated Security acquired 0.11 million shares of HD Pro. The Board of Directors of Intelligent Digital Integrated passed a resolution for the transaction on October 31, 2012.

Intelligent Digital Integrated Security Co., Ltd. (KOSE:A143160) completed the acquisition of 49.55% stake in HD Pro Co.,Ltd. on October 31, 2012.

Latest news about NewGLAB Pharma CO.,LTD

NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	04/03	CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	22/02	CI
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index	19/23/19	CI
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	05/22/05	CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	30/21/30	CI
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding	22/21/22	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding	12/21/12	CI
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	20/20/20	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	28/20/28	CI
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding	08/19/08	CI
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding	16/19/16	CI
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index	23/19/23	CI
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	19/19/19	CI
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.	04/19/04	CI
NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding	29/19/29	CI
NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding	12/19/12	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	19/18/19	CI
Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co., Ltd. for KRW 11 billion.	19/18/19	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 10.000001088 billion in funding	13/18/13	CI
HDPRO Co., Ltd. announced that it has received KRW 32.4999952 billion in funding	24/18/24	CI
HDPRO Co., Ltd. announced that it expects to receive KRW 5 billion in funding	29/17/29	CI
C&KY Holdings Co., Ltd. completed the acquisition of 14.14% stake in HDPRO Co., Ltd. from KODI CO., LTD.	30/17/30	CI
HDPRO Co., Ltd. announced that it has received KRW 10 billion in funding	24/17/24	CI
TS Holdings Co., Ltd. and 2 other shareholders completed the acquisition of 5.34% stake in HDPRO Co., Ltd. from C&KY Holdings Co., Ltd.	23/17/23	CI

Chart NewGLAB Pharma CO.,LTD

Duration

Period

More charts

Company Profile

NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.

Sector

Phones & Handheld Devices

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Phones & Handheld Devices

	1st Jan change	Capi.
NEWGLAB PHARMA CO.,LTD	-.--%	46.8M
SHENZHEN AISIDI CO., LTD.	+6.35%	1.69B
HTC CORPORATION	-15.01%	1.12B
MERRY ELECTRONICS CO., LTD.	+13.24%	840M
JNTC CO., LTD.	+54.33%	765M
SHELLY GROUP AD	+57.96%	745M
SK NETWORKS COMPANY LIMITED	-12.17%	740M
NINGBO BIRD CO.,LTD.	-29.94%	357M
OPTIEMUS INFRACOM LIMITED $Stock Optiemus Infracom Limited$	-16.73%	266M
UIL CO., LTD.	+19.93%	98.63M